Interferon lambda (IFN-λ) efficiently blocks norovirus transmission in a mouse model

Joana Rocha-Pereira1, Sophie Jacobs2, Sam Noppen1

  • 1KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.

Antiviral Research
|October 30, 2017
PubMed

Insights

Interferon lambda (IFN-λ) administration prevents norovirus transmission and disease in mice. This discovery offers a potential new strategy for controlling norovirus outbreaks and protecting vulnerable populations.

Area of Science:

  • Immunology
  • Virology
  • Gastroenterology

Background:

  • Human noroviruses cause widespread gastroenteritis outbreaks due to efficient person-to-person transmission.
  • Current norovirus outbreak control relies on disinfection and isolation, highlighting the need for novel strategies.
  • Developing models to study norovirus transmission is crucial for advancing control measures.

Purpose of the Study:

  • To investigate the role of interferon lambda (IFN-λ) in controlling norovirus infection using a mouse model.
  • To assess the protective potential of IFN-λ against murine norovirus (MNV) transmission and disease.

Main Methods:

  • A mouse-to-mouse transmission model was established using MNV-infected mice and sentinel AG129 mice (deficient in IFN-α/β and IFN-γ receptors).
  • Sentinel mice received an IFN-λ expression plasmid, leading to circulating IFN-λ and gut IFN-stimulated gene (ISG) expression.
  • Protection against MNV-induced disease, replication, inflammation, and immune response was evaluated post-exposure.

Main Results:

  • Sentinel mice exposed to MNV-infected littermates developed MNV infection and diarrhea.
  • IFN-λ administration prevented MNV-induced disease, suppressed viral replication in the small intestine, and reduced inflammation.
  • IFN-λ treatment also inhibited the development of a specific IgG-based immune response to MNV.

Conclusions:

  • Interferon lambda (IFN-λ) alone can confer protection against norovirus transmission.
  • IFN-λ administration effectively controls MNV infection and associated pathology in a susceptible mouse model.
  • Developing simple IFN-λ delivery methods could offer a novel strategy for norovirus outbreak control and protection of at-risk groups.

Related Concept Videos